FlowLite CPAP: A Contextually Appropriate CPAP for Global NICUs and SNCUs

Respiratory distress syndrome (hyaline membrane disease or RDS) is the leading cause of premature infant mortality. It is a breathing disorder of premature newborns in which the air sacs (alveoli) in the baby’s lungs do not remain open. The disease occurs in infants born under 37 weeks, and 15M premature babies are born each year with 8% expected to develop RDS. Babies with RDS have a nearly 100% mortality rate if left untreated. Effective respiratory support can improve a neonate's survival rate by 70%. In well-equipped hospitals, infants receive adequate respiratory support.

Grant ID
TTS-2002-37363
Show on Hub
On
Show on Spoke
Off
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Award Manager
Individual Funder Information
Funding Amount (in original currency)
600000.00
Funding Currency
CAD
Exchange Rate (at time of payment)
0.7500000000
Funding Amount (in USD)
450000.00
Funding Date Range
-
Funding Total (In US dollars)
450000.00
Co-Funded
False